The American Phamaceutical Company (APC) has a policy that all capital investments must have a three-year or loss discounted payback period in order to be considered for funding. The MARR at APC is 6% per year. Is the above project ablo to meet this benchmark for funding? Click the icon to view the interest and annuity table for discrete compounding when the MARR is 6% per year. The paytack period is yoars. (Round to the nearest whole number) \begin{tabular}{|c|c|c|c|c|c|c|} \hline & \multicolumn{2}{|c|}{ Single Payment } & \multicolumn{4}{|c|}{ Uniform Series } \\ \hline & CompoundAmountFactor & PresentWorthFactor & CompoundAmountFactor & PresentWorthFactor & SinkingFundFactor & CapitalRecoveryFactor \\ \hlineN & ToFindFGivenPFPP & ToFindPGivenFPIF & ToFindFGivenAFIA & ToFindPGivenAPIA & ToFindAGivenFAlF & ToFindAGivenPAlP \\ \hline 1 & 1.0600 & 0.9434 & 1.0000 & 0.9434 & 1.0000 & 1.0600 \\ \hline 2 & 1.1236 & 0.8900 & 2.0600 & 1.8334 & 0.4854 & 0.5454 \\ \hline 3 & 1.1910 & 0.8396 & 3.1836 & 2.6730 & 0.3141 & 0.3741 \\ \hline 4 & 1.2625 & 0.7921 & 4.3746 & 3.4651 & 0.2286 & 0.2886 \\ \hline 5 & 1.3382 & 0.7473 & 5.6371 & 4.2124 & 0.1774 & 0.2374 \\ \hline 6 & 1.4185 & 0.7050 & 6.9753 & 4.9173 & 0.1434 & 0.2034 \\ \hline 7 & 1.5036 & 0.6651 & 8.3938 & 5.5824 & 0.1191 & 0.1791 \\ \hline 8 & 1.5938 & 0.6274 & 9.8975 & 6.2098 & 0.1010 & 0.1610 \\ \hline 9 & 1.6895 & 0.5919 & 11.4913 & 6.8017 & 0.0870 & 0.1470 \\ \hline 10 & 17908 & 0.5584 & 131808 & 7.36n1 & 00759 & 01359 \\ \hline \end{tabular}